Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Fluid Overload Early after Allogeneic Hematopoietic Stem Cell Transplantation Was Associated with Poor Survival

Yoshimitsu Shimomura, MD, Mari Morita, MD, Hisako Hashimoto, Takayuki Ishikawa, MD PhD

Blood (2017) 130 (Supplement 1): 3233.

https://doi.org/10.1182/blood.V130.Suppl_1.3233.3233

Published: 2017

Journal Articles

Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia

Yoshimitsu Shimomura, MD, Hayato Maruoka, PhD, Tomohiro Yabushita, MD, Hisako Hashimoto, Takayuki Ishikawa, MD PhD

Blood (2017) 130 (Supplement 1): 2000.

https://doi.org/10.1182/blood.V130.Suppl_1.2000.2000

Published: 2017

Journal Articles

Low Peripheral Blood Eosinophil Counts in Patients with Acute Graft-Versus-Host-Disease Prior to Systemic Corticosteroid Therapy Is Associated with Poor Prognosis

Mari Morita, MD, Yoshimitsu Shimomura, MD, Hisako Hashimoto, MD PhD, Takayuki Ishikawa, MD PhD

Blood (2017) 130 (Supplement 1): 4489.

https://doi.org/10.1182/blood.V130.Suppl_1.4489.4489

Published: 2017

Journal Articles

The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma

Tomohiro Yabushita, MD, Hayato Maruoka, PhD, Yoshimitsu Shimomura, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD PhD, Hisako Hashimoto, MD PhD, Takayuki Ishikawa, MD PhD

Blood (2017) 130 (Supplement 1): 420.

https://doi.org/10.1182/blood.V130.Suppl_1.420.420

Published: 2017

Journal Articles

The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma

Daisuke Kato, MD, Satoshi Yoshioka, MD, PhD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2016) 128 (22): 2966.

https://doi.org/10.1182/blood.V128.22.2966.2966

Published: 2016

Journal Articles

Splenomegaly Negatively Affects Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation

Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Satoshi Yoshioka, MD, PhD, Nobuhiro Hiramoto, MD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2016) 128 (22): 2198.

https://doi.org/10.1182/blood.V128.22.2198.2198

Published: 2016

Journal Articles

Detection of Cells with Low Side Scatter and Dimmer CD45 Expression after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Good Survival

Yoshimitsu Shimomura, MD, Hayato Maruoka, M.T, Yotaro Ochi, MD, Yusuke Koba, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 3207.

https://doi.org/10.1182/blood.V126.23.3207.3207

Published: 2015

Journal Articles

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Yuichiro Ono, MD, Daisuke Kato, MD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Yukihiro Imai, MD, PhD, Hayato Maruoka, M.T, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1480.

https://doi.org/10.1182/blood.V126.23.1480.1480

Published: 2015

Journal Articles

Efficacy of High-Dose Cytarabine Added to Cyclophosphamide/Total-Body Irradiation in the Conditioning Regimen of Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancy

Yasuyuki Arai, MD, Kazunari Aoki, MD, June Takeda, MD, Tadakazu Kondo, MD, Tetsuya Eto, MD PhD, Shuichi Ota, MD, Hisako Hashimoto, MD, Takahiro Fukuda, MD, Yukiyasu Ozawa, MD, Yoshinobu Kanda, MD PhD, Chiaki Kato, MD, Mineo Kurokawa, MD, Koji Iwato, MD, Makoto Onizuka, MD, Tatsuo Ichinohe, MD, Yoshiko Atsuta, MDPhD, Akiyoshi Takami, MD

Blood (2015) 126 (23): 734.

https://doi.org/10.1182/blood.V126.23.734.734

Published: 2015

Journal Articles

The Significance of Serum Albumin Level and Platelet Count in Patients with Diffuse Large B-Cell Lymphoma in the Context of an Enhanced International Prognostic Index (NCCN-IPI)

Yotaro Ochi, MD, Yusuke Koba, MD, Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1463.

https://doi.org/10.1182/blood.V126.23.1463.1463

Published: 2015

Journal Articles

Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes

June Takeda, MD, Hiroshi Kawabata, MD, PhD, Kazunari Aoki, MD, Shuichi Shiga, S.H., Masahiro Kawahara, MD PhD, Toshio Kitawaki, MD, PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Toshiyuki Kitano, MD, Noboru Yonetani, MD, Sumie Tabata, MD, PhD, Nobuhiro Hiramoto, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, Norimitsu Kadowaki, MD PhD, Akifumi Takaori, MD, PhD

Blood (2014) 124 (21): 1907.

https://doi.org/10.1182/blood.V124.21.1907.1907

Published: 2014

Journal Articles

Risk Stratification of DLBCL Patients According to NCCN-IPI in Our Hospital

Yasuhiro Kazuma, MD, Kazunari Aoki, MD, Yotaro Ochi, MD, Yusuke Koba, MD, Yoshimitsu Shimomura, MD, Yosuke Nagahata, MD, Nobuhiko Yamauchi, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 3030.

https://doi.org/10.1182/blood.V124.21.3030.3030

Published: 2014

Journal Articles

Emergence of New lesions upon Treatment failure is an Independent, Negative Prognostic Factor for Patients with Primary Refractory DLBCL

Nobuhiko Yamauchi, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Yasuhiro Kazuma, MD, Yosuke Nagahata, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 2962.

https://doi.org/10.1182/blood.V124.21.2962.2962

Published: 2014

Journal Articles

Combined Use of Interim Positron Emission Tomography Scans and Serum Soluble Interleukin-2 Receptor Values Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

Yotaro Ochi, MD, Nobuhiko Yamauchi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, MD, Yosuke Nagahata, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Megumu Hino, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 1647.

https://doi.org/10.1182/blood.V124.21.1647.1647

Published: 2014

Journal Articles

The Significance and Optimal Number of Cycles of HD-AraC Consolidation Chemotherapy for Non-CBF AML

Yosuke Nagahata, MD, Yoshimitsu Shimomura, MD, Yotaro Ochi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, MD, Nobuhiko Yamauchi, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 2298.

https://doi.org/10.1182/blood.V124.21.2298.2298

Published: 2014

Journal Articles

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Yuichiro Ono, M.D., June Takeda, M.D., Hayato Maruoka, Yasuhiro Kazuma, M.D., Nobuhiro Hiramoto, MD, Nobuhiko Yamauchi, M.D., Yosuke Nagahata, M.D., Yuki Funayama, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Koji Nasu, Takayuki Takahashi, M.D., Ph.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 3921.

https://doi.org/10.1182/blood.V122.21.3921.3921

Published: 2013

Journal Articles

M-Protein Is Associated With Aggressive Disease In Patients With MALT Lymphoma

Nobuhiko Yamauchi, M.D., Yosuke Nagahata, M.D., Yasuhiro Kazuma, M.D., June Takeda, M.D., Yuki Funayama, M.D., Yuichiro Ono, M.D., Nobuhiro Hiramoto, M.D., Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 3008.

https://doi.org/10.1182/blood.V122.21.3008.3008

Published: 2013

Journal Articles

Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study

June Takeda, M.D., Nobuhiko Yamauchi, M.D., Kazunari Aoki, MD, Yuichiro Ono, M.D., Yuki Funayama, M.D., Yasuhiro Kazuma, M.D., Yosuke Nagahata, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Nobuhiro Hiramoto, M.D., Akiko Matsushita, M.D., Noboru Yonetani, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 5215.

https://doi.org/10.1182/blood.V122.21.5215.5215

Published: 2013

Journal Articles

Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1

Yosuke Nagahata, M.D., Yuichiro Ono, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, M.D., June Takeda, M.D., Yuki Funayama, M.D., Nobuhiko Yamauchi, M.D., Nobuhiro Hiramoto, M.D., Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 2166.

https://doi.org/10.1182/blood.V122.21.2166.2166

Published: 2013

Journal Articles

Hepatitis B and C Virus Infections Are Not Associated With Worse Clinical Outcomes After Autologous Stem Cell Transplantation: On Behalf Of The Adult Lymphoma Working Group Of The Japan Society For Hematopoietic Cell Transplantation (JSHCT)

Harumi Kato, MD, PhD, Dai Chihara, MD, PhD, Koji Kato, MD, PhD, Sung-Won Kim, MD, PhD, Takehiko Mori, MD, PhD, Masashi Sawa, MD, PhD, Yuki Ohno, MD, PhD, Hisako Hashimoto, M.D., Ph.D., Masayuki Hino, MD, PhD, Koji Iwato, MD, PhD, Takaaki Chou, MD, PhD, Hisashi Sakamaki, MD, PhD, Ritsuro Suzuki, MD, PhD, Junji Suzumiya, MD, PhD

Blood (2013) 122 (21): 4270.

https://doi.org/10.1182/blood.V122.21.4270.4270

Published: 2013

NARROW

Fluid Overload Early after Allogeneic Hematopoietic Stem Cell Transplantation Was Associated with Poor Survival

Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia

Low Peripheral Blood Eosinophil Counts in Patients with Acute Graft-Versus-Host-Disease Prior to Systemic Corticosteroid Therapy Is Associated with Poor Prognosis

The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma

The Clinical Impact of Minimal Bone Marrow Involvement on the Outcome of Patients with Follicular Lymphoma

Splenomegaly Negatively Affects Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplantation

Detection of Cells with Low Side Scatter and Dimmer CD45 Expression after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Good Survival

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Efficacy of High-Dose Cytarabine Added to Cyclophosphamide/Total-Body Irradiation in the Conditioning Regimen of Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancy

The Significance of Serum Albumin Level and Platelet Count in Patients with Diffuse Large B-Cell Lymphoma in the Context of an Enhanced International Prognostic Index (NCCN-IPI)

Clinical Impact of Complex Karyotype, Monosomal Karyotype and Acquisition of Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes

Risk Stratification of DLBCL Patients According to NCCN-IPI in Our Hospital

Emergence of New lesions upon Treatment failure is an Independent, Negative Prognostic Factor for Patients with Primary Refractory DLBCL

Combined Use of Interim Positron Emission Tomography Scans and Serum Soluble Interleukin-2 Receptor Values Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

The Significance and Optimal Number of Cycles of HD-AraC Consolidation Chemotherapy for Non-CBF AML

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

M-Protein Is Associated With Aggressive Disease In Patients With MALT Lymphoma

Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study

Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1

Hepatitis B and C Virus Infections Are Not Associated With Worse Clinical Outcomes After Autologous Stem Cell Transplantation: On Behalf Of The Adult Lymphoma Working Group Of The Japan Society For Hematopoietic Cell Transplantation (JSHCT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only